Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pain relievers label final rule not ready

This article was originally published in The Tan Sheet

Executive Summary

FDA says it "inadvertently, mistakenly posted" a Jan. 23 pre-publication notice indicating that a final rule for OTC internal analgesic product labels would be published in the Jan. 26 Federal Register. The rule would amend labels for non-steroidal anti-inflammatory drugs and acetaminophen-containing products to include warnings of gastrointestinal and liver injuries associated with improper use (1"The Tan Sheet" Jan. 26, 2009, In Brief). FDA announced the posting error Jan. 26, but did not say when the rule will be published

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102559

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel